. Author manuscript; available in PMC: 2014 May 20.

Published in final edited form as: J Thromb Haemost. 2013 Jun;11(6):1032–1042. doi: 10.1111/jth.12184

Table 2.

Cost effectiveness and projected model outputs for the two treatment strategies for a deep vein thrombosis

Output	Treatment strategy
Output	Standard treatment^*	CDT in addition to standard treatment
Costs, $	51 866	64 709
QALYs	31.68	32.31
ICER, $/QALY gained	Reference	20 429
Life expectancy, years	30.9	30.8
Patients who developed any PTS, %	62.5	44.0
Patients who developed severe PTS, %	7.6	3.3
Fatal bleeding, %	5.5	5.9
Fatal recurrent venous thromboembolism, %	4.2	3.9

QALY, quality adjusted life year; ICER, incremental cost-effectiveness ratio; CDT, catheter-directed thrombolysis; PTS, post-thrombotic syndrome.

Standard treatment included 6 months of anticoagulation and 24 months of compression therapy.